Cleared Traditional

K251748 - MammoSTAR Biopsy Site Identifier (FDA 510(k) Clearance)

Jul 2025
Decision
47d
Days
Class 2
Risk

K251748 is an FDA 510(k) clearance for the MammoSTAR Biopsy Site Identifier. This device is classified as a Marker, Radiographic, Implantable (Class II - Special Controls, product code NEU).

Submitted by Carbon Medical Technologies, Inc. (St. Paul, US). The FDA issued a Cleared decision on July 23, 2025, 47 days after receiving the submission on June 6, 2025.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4300.

Submission Details

510(k) Number K251748 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 2025
Decision Date July 23, 2025
Days to Decision 47 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NEU - Marker, Radiographic, Implantable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4300